Established in 1973 and headquartered in Mumbai, India, Alkem began operations as a health care marketing company. Alkem, one of the India's leading generic and specialty pharmaceutical companies, is a significant player in the branded drugs and generic drugs space. With a wide ranging presence across acute and chronic therapeutic segments with substantial brand share in the Anti-infective , Gastro-intestinal, Pain Management , Vitamins / Minerals / Nutritions, Central Nervous System, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressants, and Nutraceutical segments. We have developed a portfolio of 736 branded generic drugs and command market leadership,with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015. We have 16 manufacturing facilities,14 in India and 2 in US. 5 of our facilities are US FDA, TGA, UK MHRA approved. At Alkem,we produce branded generics, generic drugs, active pharmaceutical ingredient and neutraceuticals which we market in India and 55 countries internationally

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Contact information




View All Contact Info

Top Products

Seizlac 100/ 50 mg tablets (10's)

Alkem Laboratories Ltd.

3 cef novo 1.5 injection

Alkem Laboratories Ltd.

3 cef novo 375 injection

Alkem Laboratories Ltd.